Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 200 of 221

1.

Attitudes and Experiences of Men with Prostate Cancer on Risk in the Context of Injuries Related to Community-based Football - A Qualitative Study.

Rørth M, Tjørnhøj-Thomsen T, Cormie P, Oliffe JL, Midtgaard J.

J Aging Phys Act. 2018 Aug 17:1-24. doi: 10.1123/japa.2018-0089. [Epub ahead of print]

PMID:
30117362
2.

Football training over 5 years is associated with preserved femoral bone mineral density in men with prostate cancer.

Uth J, Fristrup B, Haahr RD, Brasso K, Helge JW, Rørth M, Midtgaard J, Helge EW, Krustrup P.

Scand J Med Sci Sports. 2018 Jul 12. doi: 10.1111/sms.13242. [Epub ahead of print]

PMID:
30001572
3.

The "Football is Medicine" platform-scientific evidence, large-scale implementation of evidence-based concepts and future perspectives.

Krustrup P, Williams CA, Mohr M, Hansen PR, Helge EW, Elbe AM, de Sousa M, Dvorak J, Junge A, Hammami A, Holtermann A, Larsen MN, Kirkendall D, Schmidt JF, Andersen TR, Buono P, Rørth M, Parnell D, Ottesen L, Bennike S, Nielsen JJ, Mendham AE, Zar A, Uth J, Hornstrup T, Brasso K, Nybo L, Krustrup BR, Meyer T, Aagaard P, Andersen JL, Hubball H, Reddy PA, Ryom K, Lobelo F, Barene S, Helge JW, Fatouros IG, Nassis GP, Xu JC, Pettersen SA, Calbet JA, Seabra A, Rebelo AN, Figueiredo P, Póvoas S, Castagna C, Milanovic Z, Bangsbo J, Randers MB, Brito J.

Scand J Med Sci Sports. 2018 Jun 19. doi: 10.1111/sms.13220. [Epub ahead of print] No abstract available.

PMID:
29917263
4.

Survival after bone metastasis by primary cancer type: a Danish population-based cohort study.

Svensson E, Christiansen CF, Ulrichsen SP, Rørth MR, Sørensen HT.

BMJ Open. 2017 Sep 11;7(9):e016022. doi: 10.1136/bmjopen-2017-016022.

5.

Frozen shoulder and risk of cancer: a population-based cohort study.

Pedersen AB, Horváth-Puhó E, Ehrenstein V, Rørth M, Sørensen HT.

Br J Cancer. 2017 Jun 27;117(1):144-147. doi: 10.1038/bjc.2017.146. Epub 2017 May 18.

6.
7.

Challenges in translating endpoints from trials to observational cohort studies in oncology.

Ording AG, Cronin-Fenton D, Ehrenstein V, Lash TL, Acquavella J, Rørth M, Sørensen HT.

Clin Epidemiol. 2016 Jun 11;8:195-200. doi: 10.2147/CLEP.S97874. eCollection 2016. Review.

8.

Muscle satellite cell content and mRNA signaling in germ cell cancer patients - effects of chemotherapy and resistance training.

Christensen JF, Schjerling P, Andersen JL, Daugaard G, Rørth M, Mackey AL.

Acta Oncol. 2016 Sep - Oct;55(9-10):1246-1250. doi: 10.3109/0284186X.2016.1170200. Epub 2016 May 24. No abstract available.

PMID:
27218150
9.

Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations.

Uth J, Hornstrup T, Christensen JF, Christensen KB, Jørgensen NR, Helge EW, Schmidt JF, Brasso K, Helge JW, Jakobsen MD, Andersen LL, Rørth M, Midtgaard J, Krustrup P.

Eur J Appl Physiol. 2016 Mar;116(3):471-80. doi: 10.1007/s00421-015-3301-y. Epub 2015 Nov 30.

PMID:
26620651
10.

Influence of social factors on patient-reported late symptoms: Report from a controlled trial among long-term head and neck cancer survivors in Denmark.

Kjaer TK, Johansen C, Andersen E, Karlsen R, Nielsen AL, Frederiksen K, Rørth M, Ibfelt E, Dalton SO.

Head Neck. 2016 Apr;38 Suppl 1:E1713-21. doi: 10.1002/hed.24306. Epub 2015 Nov 28.

PMID:
26613661
11.

Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.

Uth J, Hornstrup T, Christensen JF, Christensen KB, Jørgensen NR, Schmidt JF, Brasso K, Jakobsen MD, Sundstrup E, Andersen LL, Rørth M, Midtgaard J, Krustrup P, Helge EW.

Osteoporos Int. 2016 Apr;27(4):1507-1518. doi: 10.1007/s00198-015-3399-0. Epub 2015 Nov 16.

PMID:
26572756
12.

Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark.

Kjaer T, Johansen C, Andersen E, Karlsen R, Nielsen AL, Frederiksen K, Rørth M, Dalton SO.

J Cancer Surviv. 2016 Apr;10(2):251-60. doi: 10.1007/s11764-015-0471-x. Epub 2015 Jul 31.

PMID:
26227655
13.

Reply to C. Rusner et al, L.C. Pagliaro et al, and K. Lu.

Daugaard G, Kier MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, von der Maase H, Jarle Christensen I, Lauritsen J.

J Clin Oncol. 2015 Jul 10;33(20):2326-7. doi: 10.1200/JCO.2015.60.9313. Epub 2015 Jun 1. No abstract available.

PMID:
26033816
14.

Surgery After Relapse in Stage I Nonseminomatous Testicular Cancer.

Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth MR, von der Maase H, Jarle Christensen I, Lauritsen J.

J Clin Oncol. 2015 Jul 10;33(20):2322. doi: 10.1200/JCO.2014.60.2177. Epub 2015 Jun 1. No abstract available.

PMID:
26033809
15.

The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy.

Quist M, Adamsen L, Rørth M, Laursen JH, Christensen KB, Langer SW.

Integr Cancer Ther. 2015 Jul;14(4):341-9. doi: 10.1177/1534735415572887. Epub 2015 Mar 22.

PMID:
25800229
16.

Contralateral biopsy in the management of testicular cancer: what we have learned and what we need to improve.

Rørth M, Grigor KM, Jørgensen N, Skakkebaek NE, Rajpert-De Meyts E.

Andrology. 2015 Jan;3(1):99-101. doi: 10.1111/andr.12008. No abstract available.

17.

Increasing international efforts to understand and conquer testicular germ cell cancer.

Rajpert-De Meyts E, Daugaard G, Almstrup K, Jørgensen A, Rørth M, Jørgensen N, von der Maase H, Skakkebaek NE.

Andrology. 2015 Jan;3(1):1-3. doi: 10.1111/andr.12010. No abstract available.

18.

Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.

Kier MG, Lauritsen J, Almstrup K, Mortensen MS, Toft BG, Rajpert-De Meyts E, Skakkebaek NE, Rørth M, von der Maase H, Agerbaek M, Holm NV, Andersen KK, Dalton SO, Johansen C, Daugaard G.

Ann Oncol. 2015 Apr;26(4):737-42. doi: 10.1093/annonc/mdu585. Epub 2014 Dec 26.

PMID:
25542924
19.

Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.

Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, von der Maase H, Christensen IJ, Lauritsen J.

J Clin Oncol. 2014 Dec 1;32(34):3817-23. doi: 10.1200/JCO.2013.53.5831. Epub 2014 Sep 29.

PMID:
25267754
20.

Resistance training does not protect against increases in plasma cytokine levels among germ cell cancer patients during and after chemotherapy.

Christensen JF, Tolver A, Andersen JL, Rørth M, Daugaard G, Hojman P.

J Clin Endocrinol Metab. 2014 Aug;99(8):2967-76. doi: 10.1210/jc.2013-4495. Epub 2014 Jul 22.

PMID:
25050898
21.

"All boys and men can play football": a qualitative investigation of recreational football in prostate cancer patients.

Bruun DM, Krustrup P, Hornstrup T, Uth J, Brasso K, Rørth M, Christensen JF, Midtgaard J.

Scand J Med Sci Sports. 2014 Aug;24 Suppl 1:113-21. doi: 10.1111/sms.12193.

PMID:
24944135
22.

Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy.

Uth J, Hornstrup T, Schmidt JF, Christensen JF, Frandsen C, Christensen KB, Helge EW, Brasso K, Rørth M, Midtgaard J, Krustrup P.

Scand J Med Sci Sports. 2014 Aug;24 Suppl 1:105-12. doi: 10.1111/sms.12260.

PMID:
24944134
23.

Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial.

Christensen JF, Jones LW, Tolver A, Jørgensen LW, Andersen JL, Adamsen L, Højman P, Nielsen RH, Rørth M, Daugaard G.

Br J Cancer. 2014 Jul 8;111(1):8-16. doi: 10.1038/bjc.2014.273. Epub 2014 May 27.

24.

Community-based recreational football: a novel approach to promote physical activity and quality of life in prostate cancer survivors.

Bruun DM, Bjerre E, Krustrup P, Brasso K, Johansen C, Rørth M, Midtgaard J.

Int J Environ Res Public Health. 2014 May 26;11(6):5567-85. doi: 10.3390/ijerph110605567.

25.

Exercise despite pain--breast cancer patient experiences of muscle and joint pain during adjuvant chemotherapy and concurrent participation in an exercise intervention.

Andersen C, Rørth M, Ejlertsen B, Adamsen L.

Eur J Cancer Care (Engl). 2014 Sep;23(5):653-67. doi: 10.1111/ecc.12192. Epub 2014 Apr 21.

PMID:
24750506
26.

Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre.

De Lichtenberg TH, Hermann GG, Rørth M, Højer Larsen MJ, Mansourvar Z, Holm ML, Scheike T.

Scand J Urol. 2014 Aug;48(4):379-86. doi: 10.3109/21681805.2013.876550. Epub 2014 Feb 12.

PMID:
24521185
27.

Muscle dysfunction in cancer patients.

Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P.

Ann Oncol. 2014 May;25(5):947-58. doi: 10.1093/annonc/mdt551. Epub 2014 Jan 8. Review.

PMID:
24401927
28.

Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.

Uth J, Schmidt JF, Christensen JF, Hornstrup T, Andersen LJ, Hansen PR, Christensen KB, Andersen LL, Helge EW, Brasso K, Rørth M, Krustrup P, Midtgaard J.

BMC Cancer. 2013 Dec 13;13:595. doi: 10.1186/1471-2407-13-595.

30.

Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: a randomized, controlled trial.

Midtgaard J, Christensen JF, Tolver A, Jones LW, Uth J, Rasmussen B, Tang L, Adamsen L, Rørth M.

Ann Oncol. 2013 Sep;24(9):2267-73. doi: 10.1093/annonc/mdt185. Epub 2013 May 23.

31.

Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study.

Urup T, Pawlak WZ, Petersen PM, Pappot H, Rørth M, Daugaard G.

Br J Cancer. 2013 May 28;108(10):1994-7. doi: 10.1038/bjc.2013.229. Epub 2013 May 7.

32.

[Treatment of adrenocortical carcinomas is challenging].

Abildgaard J, Pappot H, Petersen PM, Rørth M, Rasmussen ÅK, Toft BG, Sommer P, Daugaard G.

Ugeskr Laeger. 2013 Apr 22;175(17):1181-5. Review. Danish.

PMID:
23651782
33.

[Lack of uniformity in the treatment of thymomas].

Abildgaard J, Pappot H, Petersen PM, Rørth M, Pedersen JH, Santoni-Rugiu E, Daugaard G.

Ugeskr Laeger. 2012 Dec 10;174(50):3164-9. Danish.

PMID:
23286768
34.

The effects of a six-week supervised multimodal exercise intervention during chemotherapy on cancer-related fatigue.

Andersen C, Rørth M, Ejlertsen B, Stage M, Møller T, Midtgaard J, Quist M, Bloomquist K, Adamsen L.

Eur J Oncol Nurs. 2013 Jun;17(3):331-9. doi: 10.1016/j.ejon.2012.09.003. Epub 2012 Oct 16.

PMID:
23084254
35.

Intracranial germ cell tumours. A review with special reference to endocrine manifestations.

Jorsal T, Rørth M.

Acta Oncol. 2012 Jan;51(1):3-9. doi: 10.3109/0284186X.2011.586000. Review.

PMID:
22150165
36.

The effect of honey-coated bandages compared with silver-coated bandages on treatment of malignant wounds-a randomized study.

Lund-Nielsen B, Adamsen L, Kolmos HJ, Rørth M, Tolver A, Gottrup F.

Wound Repair Regen. 2011 Nov;19(6):664-70. doi: 10.1111/j.1524-475X.2011.00735.x. Epub 2011 Oct 13.

PMID:
22092836
37.

Demonstration and manifestation of self-determination and illness resistance--a qualitative study of long-term maintenance of physical activity in posttreatment cancer survivors.

Midtgaard J, Røssell K, Christensen JF, Uth J, Adamsen L, Rørth M.

Support Care Cancer. 2012 Sep;20(9):1999-2008. doi: 10.1007/s00520-011-1304-8. Epub 2011 Nov 15.

PMID:
22083498
38.
39.

Multifocal intracranial germinoma with raised tumour markers in serum but not in CSF and with carcinoma in situ of the testis.

Jorsal T, Rørth M.

Acta Oncol. 2012 Jan;51(1):127-9. doi: 10.3109/0284186X.2011.604344. Epub 2011 Aug 22. No abstract available.

PMID:
21859353
40.

Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study.

Quist M, Rørth M, Langer S, Jones LW, Laursen JH, Pappot H, Christensen KB, Adamsen L.

Lung Cancer. 2012 Feb;75(2):203-8. doi: 10.1016/j.lungcan.2011.07.006. Epub 2011 Aug 3.

PMID:
21816503
41.
42.

The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer.

Bandak M, Aksglaede L, Juul A, Rørth M, Daugaard G.

Eur J Cancer. 2011 Nov;47(17):2585-91. doi: 10.1016/j.ejca.2011.05.026. Epub 2011 Jun 23.

PMID:
21704509
43.

[Breakthroughs in cancer treatment].

Rørth M.

Ugeskr Laeger. 2011 Jun 13;173(24):1721-4. Danish.

PMID:
21696676
44.

Exercise and relaxation intervention for patients with advanced lung cancer: a qualitative feasibility study.

Adamsen L, Stage M, Laursen J, Rørth M, Quist M.

Scand J Med Sci Sports. 2012 Dec;22(6):804-15. doi: 10.1111/j.1600-0838.2011.01323.x. Epub 2011 May 23.

PMID:
21599754
45.

An avalanche of ignoring--a qualitative study of health care avoidance in women with malignant breast cancer wounds.

Lund-Nielsen B, Midtgaard J, Rørth M, Gottrup F, Adamsen L.

Cancer Nurs. 2011 Jul-Aug;34(4):277-85. doi: 10.1097/NCC.0b013e3182025020.

PMID:
21252644
46.

Exercise may reduce depression but not anxiety in self-referred cancer patients undergoing chemotherapy. Post-hoc analysis of data from the 'Body & Cancer' trial.

Midtgaard J, Stage M, Møller T, Andersen C, Quist M, Rørth M, Herrstedt J, Vistisen K, Christiansen B, Adamsen L.

Acta Oncol. 2011 Jun;50(5):660-9. doi: 10.3109/0284186X.2010.543145. Epub 2011 Jan 12.

PMID:
21226544
47.

Effects of Darbepoetin Alfa with exercise in cancer patients undergoing chemotherapy: an explorative study.

Rørth M, Madsen KR, Burmølle SH, Midtgaard J, Andersen C, Nielsen B, Stage M, Adamsen L.

Scand J Med Sci Sports. 2011 Jun;21(3):369-77. doi: 10.1111/j.1600-0838.2009.01066.x. Epub 2010 Jan 31.

PMID:
20136754
48.

Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial.

Adamsen L, Quist M, Andersen C, Møller T, Herrstedt J, Kronborg D, Baadsgaard MT, Vistisen K, Midtgaard J, Christiansen B, Stage M, Kronborg MT, Rørth M.

BMJ. 2009 Oct 13;339:b3410. doi: 10.1136/bmj.b3410.

49.

Self-reported physical activity behaviour; exercise motivation and information among Danish adult cancer patients undergoing chemotherapy.

Midtgaard J, Baadsgaard MT, Møller T, Rasmussen B, Quist M, Andersen C, Rørth M, Adamsen L.

Eur J Oncol Nurs. 2009 Apr;13(2):116-21. doi: 10.1016/j.ejon.2009.01.006. Epub 2009 Feb 20.

PMID:
19230768
50.

Struggling with cancer and treatment: young athletes recapture body control and identity through exercise: qualitative findings from a supervised group exercise program in cancer patients of mixed gender undergoing chemotherapy.

Adamsen L, Andersen C, Midtgaard J, Møller T, Quist M, Rørth M.

Scand J Med Sci Sports. 2009 Feb;19(1):55-66. doi: 10.1111/j.1600-0838.2007.00767.x. Epub 2008 Feb 4.

PMID:
18266788
51.

Does more than one biopsy of the contralateral testis in men with a germ cell tumor add value?

Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Rorth M, Jorgensen N, Skakkebaek NE.

Nat Clin Pract Urol. 2007 Dec;4(12):652-3. Epub 2007 Oct 23. No abstract available.

PMID:
17955048
53.

Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.

Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rørth M, Krarup C.

Brain. 2007 Apr;130(Pt 4):1076-88. Epub 2007 Feb 14.

PMID:
17301082
54.

Maximum physical capacity testing in cancer patients undergoing chemotherapy: qualitative findings from an exercise program.

Knutsen L, Quist M, Midtgaard J, Rorth M, Adamsen L.

Scand J Med Sci Sports. 2006 Dec;16(6):403-11.

PMID:
17121642
55.

High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy.

Quist M, Rorth M, Zacho M, Andersen C, Moeller T, Midtgaard J, Adamsen L.

Scand J Med Sci Sports. 2006 Oct;16(5):349-57.

PMID:
16978255
57.

Precursor lesions in testis and dysgenetic gonads.

von Eyben FE, Jacobsen GK, Skotheim RI, von der Maase H, Rorth M.

Hum Pathol. 2006 Jun;37(6):773; author reply 774. Epub 2006 Mar 13. No abstract available.

PMID:
16733221
58.

The impact of a multidimensional exercise program on self-reported anxiety and depression in cancer patients undergoing chemotherapy: a phase II study.

Midtgaard J, Rørth M, Stelter R, Tveterås A, Andersen C, Quist M, Møller T, Adamsen L.

Palliat Support Care. 2005 Sep;3(3):197-208.

PMID:
16594459
59.

The effect of a multidimensional exercise programme on symptoms and side-effects in cancer patients undergoing chemotherapy--the use of semi-structured diaries.

Andersen C, Adamsen L, Moeller T, Midtgaard J, Quist M, Tveteraas A, Rorth M.

Eur J Oncol Nurs. 2006 Sep;10(4):247-62. Epub 2006 Feb 14.

PMID:
16476570
60.

[Erythropoietin for patients with malignant disease. An analysis of a systematic Cochrane review].

Specht LK, Rørth M.

Ugeskr Laeger. 2006 Feb 6;168(6):566-9. Review. Danish. No abstract available.

PMID:
16476216
61.
62.

The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy.

Adamsen L, Quist M, Midtgaard J, Andersen C, Møller T, Knutsen L, Tveterås A, Rorth M.

Support Care Cancer. 2006 Feb;14(2):116-27. Epub 2005 Aug 12.

PMID:
16096771
63.

Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy.

Adamsen L, Midtgaard J, Andersen C, Quist M, Moeller T, Roerth M.

Eur J Cancer Care (Engl). 2004 Sep;13(4):362-70.

PMID:
15305905
64.

Microinvasive germ cell tumour (MGCT) adjacent to testicular germ cell tumours.

von Eyben FE, Jacobsen GK, Rorth M, Von Der Maase H.

Histopathology. 2004 Jun;44(6):547-54.

PMID:
15186269
65.

[Cancer--a public disease?].

Storm HH, Rørth M.

Ugeskr Laeger. 2004 Mar 29;166(14):1327-31. Review. Danish. No abstract available.

PMID:
15101122
66.

Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy.

Adamsen L, Midtgaard J, Rorth M, Borregaard N, Andersen C, Quist M, Møller T, Zacho M, Madsen JK, Knutsen L.

Support Care Cancer. 2003 Nov;11(11):707-16. Epub 2003 Jul 24.

PMID:
12898370
67.

Endocrine function in patients treated for carcinoma in situ in the testis with irradiation.

Petersen PM, Daugaard G, Rørth M, Skakkebaek NE.

APMIS. 2003 Jan;111(1):93-8; discussion 98-9. Review.

PMID:
12752244
68.

Surveillance in stage I testicular cancer.

Daugaard G, Petersen PM, Rørth M.

APMIS. 2003 Jan;111(1):76-83; discussion 83-5.

PMID:
12752240
69.

Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.

Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M.

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9.

PMID:
12634968
70.

[Cancer in Denmark--diagnosis and prevention].

Rørth M.

Ugeskr Laeger. 2002 May 27;164(22):2853. Danish. No abstract available.

PMID:
12082809
71.

Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis.

Petersen PM, Giwercman A, Daugaard G, Rørth M, Petersen JH, Skakkeaek NE, Hansen SW, von der Maase H.

J Clin Oncol. 2002 Mar 15;20(6):1537-43.

PMID:
11896102
72.

[Palliative medicine].

Rørth M.

Ugeskr Laeger. 2002 Jan 21;164(4):463. Danish. No abstract available.

PMID:
11838411
73.

Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I.

von Eyben FE, Madsen EL, Blaabjerg O, Petersen PH, von der Maase H, Jacobsen GK, Rørth M.

Acta Oncol. 2001;40(4):536-40.

PMID:
11504315
74.

Carcinoma in situ in the testis.

Rørth M, Rajpert-De Meyts E, Andersson L, Dieckmann KP, Fosså SD, Grigor KM, Hendry WF, Herr HW, Looijenga LH, Oosterhuis JW, Skakkebaek NE.

Scand J Urol Nephrol Suppl. 2000;(205):166-86. Review.

PMID:
11144894
75.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1999;18:336-56. Review.

PMID:
10800491
76.

[Testicular cancer. Development of effective medical treatment for young cancer patients].

Rørth M.

Ugeskr Laeger. 2000 Jan 3;162(1):28-9. Danish. No abstract available.

PMID:
10658486
77.

Multidrug resistance and retroviral transduction potential in human small cell lung cancer cell lines.

Theilade MD, Gram GJ, Jensen PB, Cianfriglia M, Rørth M, Hansen JE.

APMIS. 1999 Sep;107(9):851-8.

PMID:
10519321
78.

Impaired testicular function in patients with carcinoma-in-situ of the testis.

Petersen PM, Giwercman A, Hansen SW, Berthelsen JG, Daugaard G, Rørth M, Skakkebaek NE.

J Clin Oncol. 1999 Jan;17(1):173-9.

PMID:
10458231
80.

Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study.

Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rørth M, Schmalbruch H.

Neuropathol Appl Neurobiol. 1999 Feb;25(1):29-40.

PMID:
10194773
81.

Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.

Petersen PM, Skakkebaek NE, Vistisen K, Rørth M, Giwercman A.

J Clin Oncol. 1999 Mar;17(3):941-7.

PMID:
10071288
82.

Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer.

Petersen PM, Skakkebaek NE, Rørth M, Giwercman A.

J Urol. 1999 Mar;161(3):822-6.

PMID:
10022693
83.

Undetectable inhibin B serum levels in men after testicular irradiation.

Petersen PM, Andersson AM, Rørth M, Daugaard G, Skakkebaek NE.

J Clin Endocrinol Metab. 1999 Jan;84(1):213-5.

PMID:
9920086
84.

[Treatment of cancer patients in the Nordic countries].

Rørth M, Storm HH.

Nord Med. 1998 Nov;113(9):293-6. Danish.

PMID:
9835759
85.

Gonadal function in men with testicular cancer.

Petersen PM, Giwercman A, Skakkebaek NE, Rørth M.

Semin Oncol. 1998 Apr;25(2):224-33. Review.

PMID:
9562456
86.

[Nurse missing].

Rørth M.

Sygeplejersken. 1998 Feb 6;98(6):31. Danish. No abstract available.

PMID:
9528594
87.

[Back pain--time for a little science?].

Stender S, Rørth M, Rehfeld JF, Plum P, Dyhr L, Clausen T, Astrup AV.

Ugeskr Laeger. 1998 Jan 12;160(3):295-6. Danish. No abstract available.

PMID:
9454402
88.

Transduction potential of human retroviruses in highly proliferating small-cell lung cancer cells as well as non-proliferating hematopoietic stem cells.

Hansen JE, Gram GJ, Nielsen SD, Sørensen A, Jensen PB, Sehested M, Nielsen JO, Rørth M.

APMIS. 1997 Sep;105(9):723-9.

PMID:
9350217
89.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1997;17:444-63. Review.

PMID:
9551225
90.

[Medical treatment of cancer].

Dombernowsky, Hansen HH, Hansen M, Hansen MM, Hansen NE, Mouridsen H, Rørth M.

Ugeskr Laeger. 1997;159 Suppl 3:1-14. Danish. No abstract available.

PMID:
9229892
91.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1996;16:474-86. Review.

PMID:
8639395
93.

Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer.

Petersen PM, Hansen SW, Giwercman A, Rørth M, Skakkebaek NE.

Ann Oncol. 1994 Apr;5(4):355-8.

PMID:
8075033
94.

Current concepts of radiation treatment of carcinoma in situ of the testis.

Giwercman A, von der Maase H, Rørth M, Skakkebaek NE.

World J Urol. 1994;12(3):125-30. Review.

PMID:
7951337
95.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1994;15:484-500. Review.

PMID:
7779593
96.

A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.

Filtenborg TA, Hansen HH, Aage Engelholm S, Rørth M.

Ann Oncol. 1993 Jun;4(6):485-8.

PMID:
8353091
97.

Semen quality in testicular tumour and CIS in the contralateral testis.

Giwercman A, von der Maase H, Rørth M, Skakkebaek NE.

Lancet. 1993 Feb 6;341(8841):384-5. No abstract available.

PMID:
8094162
98.

Should the contralateral testis be biopsied? Round table discussion.

Grigor KM, Rørth M.

Eur Urol. 1993;23(1):129-35.

PMID:
8477772
99.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1993;14:442-61. Review.

PMID:
8312112
100.

Surveillance following orchidectomy for stage I seminoma of the testis.

von der Maase H, Specht L, Jacobsen GK, Jakobsen A, Madsen EL, Pedersen M, Rørth M, Schultz H.

Eur J Cancer. 1993;29A(14):1931-4.

PMID:
8280484
101.

Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.

Skov T, Maarup B, Olsen J, Rørth M, Winthereik H, Lynge E.

Br J Ind Med. 1992 Dec;49(12):855-61.

102.

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.

Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen SO, Rørth M, Mouridsen H, Dombernowsky P.

J Clin Oncol. 1992 Sep;10(9):1444-51.

PMID:
1517787
103.

Therapeutic alternatives in clinical stage I nonseminomatous disease.

Rørth M.

Semin Oncol. 1992 Apr;19(2):190-6. Review. No abstract available.

PMID:
1553572
104.
105.

Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies.

Daugaard G, Rørth M, von der Maase H, Skakkebaek NE.

Ann Oncol. 1992 Apr;3(4):283-9.

PMID:
1327076
106.

Secondary surgery in patients with malignant germ cell tumors.

Rasmussen OV, Daugaard G, Christiansen S, Sørensen BL, Rørth M.

J Urol. 1992 Feb;147(2):393-7.

PMID:
1310123
107.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1992;13:455-70. Review.

PMID:
1327045
108.

[Cytostatics--work environment. Reassuring studies--but need for more].

Skov T, Olsen J, Rørth M, Maarup B, Winthereik H, Lynge E.

Sygeplejersken. 1991 Nov 27;91(48):4-7. Danish. No abstract available.

PMID:
1808751
109.

[Alternative treatment--what can we learn?].

Rørth M.

Ugeskr Laeger. 1991 Nov 18;153(47):3303. Danish. No abstract available.

PMID:
1957387
110.

Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients.

Giwercman A, von der Maase H, Berthelsen JG, Rørth M, Bertelsen A, Skakkebaek NE.

J Clin Endocrinol Metab. 1991 Sep;73(3):596-603.

PMID:
1908483
111.

Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.

Rørth M, Jacobsen GK, von der Maase H, Madsen EL, Nielsen OS, Pedersen M, Schultz H.

J Clin Oncol. 1991 Sep;9(9):1543-8.

PMID:
1714948
112.

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours.

Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larsen SO, Rørth M.

Lancet. 1991 Aug 10;338(8763):359-63.

PMID:
1713639
113.

[Fertility in patients treated for germinal ovarian tumors].

Frölich AE, Rørth M.

Ugeskr Laeger. 1991 Jul 8;153(28):2005-7. Danish.

PMID:
1650512
114.

Testis cancer. Ichthyosis constitutes a significant risk factor.

Lykkesfeldt G, Bennett P, Lykkesfeldt AE, Micic S, Rørth M, Skakkebaek NE, Svenstrup B.

Cancer. 1991 Feb 1;67(3):730-4.

PMID:
1898710
115.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1991;12:443-59. Review. No abstract available.

PMID:
1657089
116.

Risks for physicians handling antineoplastic drugs.

Skov T, Lynge E, Maarup B, Olsen J, Rørth M, Winthereik H.

Lancet. 1990 Dec 8;336(8728):1446. No abstract available.

PMID:
1978899
117.
118.

Histopathological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse. Danish Testicular Cancer Study Group.

Jacobsen GK, Rørth M, Osterlind K, von der Maase H, Jacobsen A, Madsen EL, Pedersen M, Schultz H.

APMIS. 1990 Apr;98(4):377-82.

PMID:
2162186
119.

[Atypical manifestation of extragonadal germinative tumors].

Kryger-Baggesen N, Rørth M.

Ugeskr Laeger. 1990 Mar 19;152(12):824-5. Danish.

PMID:
2316044
120.

CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.

Hørding U, Toftager-Larsen K, Dreisler A, Lund B, Daugaard S, Lundvall F, Arends J, Winkel P, Rørth M.

Gynecol Obstet Invest. 1990;30(3):178-83.

PMID:
2265805
121.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1990;11:432-52. Review. No abstract available.

PMID:
2171611
122.

Management of patients with non-seminomatous germ cell tumours stage I.

Rørth M, Cullen MH, Horwich A, Roth BJ.

Prog Clin Biol Res. 1990;357:295-303. Review. No abstract available.

PMID:
2170995
123.

Treatment of malignant germ cell tumors.

Daugaard G, Hansen HH, Rørth M.

Ann Oncol. 1990;1(3):195-202.

PMID:
1702008
124.

Effects of antineoplastic treatment of HIV-positive patients with testicular cancer.

Damstrup L, Daugaard G, Gerstoft J, Rørth M.

Eur J Cancer Clin Oncol. 1989 Jun;25(6):983-6.

PMID:
2473906
125.

Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cis-platinum, vinblastine and bleomycin: a long-term follow-up.

Hansen SW, Groth S, Sørensen PG, Rossing N, Rørth M.

Eur J Cancer Clin Oncol. 1989 Apr;25(4):733-6.

PMID:
2469589
126.

Palliative irradiation of bone metastases.

Poulsen HS, Nielsen OS, Klee M, Rørth M.

Cancer Treat Rev. 1989 Mar;16(1):41-8. Review.

PMID:
2471589
127.

[Cancer treatment].

Rørth M, Skovgaard Poulsen H.

Ugeskr Laeger. 1989 Jan 30;151(5):325-9. Danish. No abstract available.

PMID:
2919453
128.

Prevention of bilateral testicular cancer: significance of detection and treatment of carcinoma in situ.

Skakkebaek NE, Berthelsen JG, von der Maase H, Rørth M, Osterlind A.

Prog Clin Biol Res. 1989;303:779-89. Review. No abstract available.

PMID:
2550951
129.
130.

[Testicular carcinoma in situ].

Skakkebaek NE, Berthelsen JG, Müller J, Giwercman A, von der Maase H, Rørth M.

Ugeskr Laeger. 1988 Sep 12;150(37):2154-7. Danish. No abstract available.

PMID:
3206575
131.

[Medical treatment of cancer--an elucidating report].

Dombernowsky P, Hansen HH, Hansen NE, Mouridsen H, Nissen NI, Rørth M.

Ugeskr Laeger. 1988 Sep 5;150(36):2106-13. Danish. No abstract available.

PMID:
3188266
132.

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

Daugaard G, Rossing N, Rørth M.

Cancer Chemother Pharmacol. 1988;21(2):163-7.

PMID:
3280153
133.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1988;10:222-40. Review. No abstract available.

PMID:
2856328
134.

Carcinoma-in-situ testis in patients with assumed extragonadal germ-cell tumours.

Daugaard G, von der Maase H, Olsen J, Rørth M, Skakkebaek NE.

Lancet. 1987 Sep 5;2(8558):528-30.

PMID:
2887831
135.
136.
137.

Management of advanced metastatic germ cell tumours.

Daugaard G, Hansen HH, Rørth M.

Int J Androl. 1987 Feb;10(1):319-24.

PMID:
2438225
138.

[Cytostatic treatment of metastatic adenocarcinoma and anaplastic carcinoma of unknown primary origin].

Aabo K, Rørth M, Hansen HH.

Ugeskr Laeger. 1987 Jan 5;149(2):80-1. Danish. No abstract available.

PMID:
3810973
139.

Immature ovarian teratoma in a postmenopausal woman.

Ornvold K, Detlefsen GU, Horn T, Rørth M.

Acta Obstet Gynecol Scand. 1987;66(5):473-6.

PMID:
3425249
140.

Lung cancer.

Hansen HH, Rørth M.

Cancer Chemother Biol Response Modif. 1987;9:239-56. Review. No abstract available.

PMID:
2856335
141.

Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.

von der Maase H, Rørth M, Walbom-Jørgensen S, Sørensen BL, Christophersen IS, Hald T, Jacobsen GK, Berthelsen JG, Skakkebaek NE.

Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1398-401.

142.

[Poor quality in report on cytostatic agents].

Rørth M.

Sygeplejersken. 1986 Aug 27;86(35):33. Danish. No abstract available.

PMID:
3639638
143.

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up.

Osterlind K, Hansen HH, Hansen HS, Dombernowsky P, Hansen M, Rørth M.

Br J Cancer. 1986 Jul;54(1):7-17.

144.

Treatment of persistent or relapsing advanced germ cell neoplasms with cisplatin, etoposide and bleomycin.

Hansen SW, Daugaard G, Rørth M.

Eur J Cancer Clin Oncol. 1986 May;22(5):595-9.

PMID:
2429840
145.

Acute and long-term nephrotoxicity of cis-platinum in man.

Groth S, Nielsen H, Sørensen JB, Christensen AB, Pedersen AG, Rørth M.

Cancer Chemother Pharmacol. 1986;17(2):191-6.

PMID:
2424627
146.

Second cancer following cancer of the male genital system in Denmark, 1943-80.

Osterlind A, Rørth M, Prener A.

Natl Cancer Inst Monogr. 1985 Dec;68:341-7.

PMID:
4088308
147.

Leukemia following treatment of germ cell tumors in men.

Pedersen-Bjergaard J, Rørth M, Nissen NI, Philip P.

J Clin Oncol. 1985 Jun;3(6):885-7. No abstract available.

PMID:
2989447
148.

Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.

Sørensen PG, Rossing N, Rørth M.

Eur J Respir Dis. 1985 May;66(5):333-40.

PMID:
2410287
149.

Cisplatin in the treatment of advanced gastric carcinoma: a phase II study.

Aabo K, Pedersen H, Rørth M.

Cancer Treat Rep. 1985 Apr;69(4):449-50.

PMID:
4039628
150.
151.
152.
153.

[Germ cell tumors of the ovary].

Hørding U, Rørth M.

Ugeskr Laeger. 1985 Feb 25;147(9):784-8. Danish. No abstract available.

PMID:
3984082
154.

Carcinoma-in-situ of testis eradicated by chemotherapy.

von der Maase H, Berthelsen JG, Jacobsen GK, Hald T, Rørth M, Christophersen IS, Sørensen BL, Walbom-Jørgensen S, Skakkebaek NE.

Lancet. 1985 Jan 12;1(8420):98. No abstract available.

PMID:
2857040
155.

Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?

Sørensen PG, Nissen MH, Groth S, Rørth M.

Cancer Chemother Pharmacol. 1985;14(3):247-9.

PMID:
3922640
156.

Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056).

Sørensen JB, Groth S, Hansen SW, Nissen MH, Rørth M, Hansen HH.

Cancer Chemother Pharmacol. 1985;15(2):97-100.

PMID:
3893780
157.

Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapy.

Nielsen H, Rørth M, Bennedsen J.

Cancer Immunol Immunother. 1985;19(1):68-71.

PMID:
3844976
159.

Treatment of non-seminomatous testicular germ cell tumors in Denmark since 1979.

Rørth M, von der Maase H, Nielsen ES, Schultz H, Pedersen M.

Prog Clin Biol Res. 1985;203:539-51. No abstract available.

PMID:
3008183
160.

The Danish Testicular Carcinoma Study. Results from recent clinical trials in non-seminomatous tumours.

Schultz HP, Rørth M, von der Maase H, Sandberg E, Pedersen M.

Acta Urol Belg. 1985;53(2):362-76. English, French. No abstract available.

PMID:
2990182
161.
162.

Prognostic value of changes in tumor marker concentrations during treatment of patients with testicular cancer.

Nielsen H, Hansen SW, Ernst P, Rørth M.

Cancer Treat Rep. 1984 Nov;68(11):1422-3. No abstract available.

PMID:
6209010
163.

Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.

Daugaard G, Hansen HH, Rørth M.

Cancer Treat Rep. 1984 Sep;68(9):1179-81.

PMID:
6090016
164.
165.

Pulmonary blastoma: remission with chemotherapy.

Nissen MH, Jacobsen M, Vindeløv L, Olsen J, Rørth M.

Eur J Respir Dis. 1984 Jul;65(5):377-9.

PMID:
6086368
166.

[Treatment of extragonadal germinative tumors].

Daugaard KG, Rørth M, Hansen HH.

Ugeskr Laeger. 1984 Mar 19;146(12):876-8. Danish. No abstract available.

PMID:
6719586
167.

Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.

Rørth M, von der Maase H, Sandberg Nielsen E, Schultz HP, Svennekjaer IL.

Acta Radiol Oncol. 1984;23(4):295-304.

PMID:
6208750
168.

Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.

Nørgaard-Pedersen B, Schultz HP, Arends J, Brincker H, Krag Jacobsen G, Lindeløv B, Rørth M, Svennekjaer IL.

Acta Radiol Oncol. 1984;23(4):287-94.

PMID:
6208749
169.

Testicular seminoma in Denmark 1976-1980. Results of treatment.

Schultz HP, von der Maase H, Rørth M, Pedersen M, Sandberg Nielsen E, Walbom-Jørgensen S.

Acta Radiol Oncol. 1984;23(4):263-70.

PMID:
6208748
170.

Non-seminomatous testicular germ cell tumours in Denmark 1976-1980. Results of treatment.

von der Maase H, Engelholm SA, Rørth M, Sandberg Nielsen E, Schultz HP, Svennekjaer IL, Vaeth M.

Acta Radiol Oncol. 1984;23(4):255-61.

PMID:
6208747
171.

Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.

Osterlind K, Sörenson S, Hansen HH, Dombernowsky P, Hirsch FR, Hansen M, Rørth M.

Cancer Res. 1983 Dec;43(12 Pt 1):6085-9.

172.

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.

Løber J, Mouridsen HT, Christiansen IE, Dombernowsky P, Mattsson W, Rørth M.

Cancer. 1983 Nov 1;52(9):1570-6.

PMID:
6352005
173.

Combination chemotherapy for malignant thymoma.

Daugaard G, Hansen HH, Rørth M.

Ann Intern Med. 1983 Aug;99(2):189-90. No abstract available.

PMID:
6881774
174.

Therapy of extragonadal germ-cell tumors.

Daugaard G, Rørth M, Hansen HH.

Eur J Cancer Clin Oncol. 1983 Jul;19(7):895-9.

PMID:
6192996
175.

Phase I evaluation of peplomycin with special reference to pulmonary toxicity.

Sørensen PG, Rørth M, Hansen HH.

Eur J Cancer Clin Oncol. 1983 Mar;19(3):319-25.

PMID:
6190655
176.

[Mutagenic substances in the urine of nurses in an oncological department].

Rørth M, Jørgensen J, Jørgensen V, Knudsen I, Larsen JC, Munck F.

Ugeskr Laeger. 1983 Feb 14;145(7):475-8. Danish. No abstract available.

PMID:
6845511
177.

Serum testosterone, LH, and FSH in patients with testicular cancer before and after radio- and chemotherapy.

Berthelsen JG, Engelholm SA, von der Maase H, Rørth M.

Scand J Urol Nephrol. 1983;17(3):287-90.

PMID:
6316483
178.

Secondary surgery in advanced testicular germ-cell tumors.

Brünner N, Rørth M, Schultz H, Nielsen ES, Sørensen BL, Genster H, Mogensen P, Madsen CM.

Scand J Urol Nephrol. 1983;17(3):283-5.

PMID:
6316482
179.

Staging and prognostic factors in small cell carcinoma of the lung.

Osterlind K, Ihde DC, Ettinger DS, Gralla RJ, Karrer K, Krauss S, Maurer LH, Rørth M, Sörenson S, Vincent R.

Cancer Treat Rep. 1983 Jan;67(1):3-9. No abstract available.

PMID:
6311412
180.

Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.

Nørgaard-Pedersen B, Schultz H, Arends J, Brincker H, Jacobsen GK, Lindeløv B, Rørth M, Svennekjaer IL.

Ann N Y Acad Sci. 1983;417:390-9.

PMID:
6200044
181.

A phase II trial of peplomycin in squamous cell carcinoma of the lung.

Sørensen PG, Rørth M, Hansen HH, Dombernowsky P, Høst H.

Eur J Cancer Clin Oncol. 1983 Jan;19(1):25-7.

PMID:
6189718
182.

cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II study.

Lund B, Aabo K, Rørth M, Hansen HH.

Eur J Cancer Clin Oncol. 1982 Nov;18(11):1089-92.

PMID:
6819145
183.

Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.

Osterlind K, Hørbov S, Dombernowsky P, Rørth M, Hansen HH.

Cancer Treat Rep. 1982 Feb;66(2):305-9.

PMID:
7055816
184.

Organisation of the Danish adjuvant trials in breast cancer.

Andersen KW, Mouridsen HT, Castberg T, Fischerman K, Andersen J, Hou-Jensen K, Brincker H, Johansen H, Henriksen E, Rørth M, Rossing N.

Dan Med Bull. 1981 Aug;28(3):102-6. No abstract available.

PMID:
7273865
185.

Selection of high risk groups among prognostically favorable patients with breast cancer.

Andersen JA, Fischermann K, Hou-Jensen K, Henriksen E, Andersen KW, Johansen H, Brincker H, Mouridsen HT, Castberg T, Rossing N, Rørth M.

Ann Surg. 1981 Jul;194(1):1-3.

186.

5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.

Havsteen H, Sörenson S, Rørth M, Dombernowsky P, Hansen HH.

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):123-5.

PMID:
6261945
187.

[Cis-diaminodichloroplatinum (Cis-platin). A new cytostatic of special importance in the treatment of testicular cancer].

Rørth M.

Ugeskr Laeger. 1980 Oct 6;142(41):2713-6. Danish. No abstract available.

PMID:
7192445
188.

[Combination chemotherapy of disseminated non-seminomatous testicular cancer. Combined with cis-diaminodichloroplatinum, vinblastine and bleomycin therapy].

Rørth M, Hansen M, Hansen HH, von der Maase H.

Ugeskr Laeger. 1980 Oct 6;142(41):2691-3. Danish. No abstract available.

PMID:
6160668
189.

Small-cell carcinoma of the bronchus.

Hansen HH, Hansen M, Rørth M, Dombernowsky P.

Lancet. 1980 Feb 23;1(8165):416. No abstract available.

PMID:
6101859
190.

A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.

Rørth M, Løber J, Dombernowsky P, Krusenstjerna-Hofstrom D, Mattsson W, Mouridsen HT.

Eur J Cancer. 1980;Suppl 1:137-40. No abstract available.

PMID:
7032923
191.

Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.

Mouridsen HT, Salimtschik M, Dombernowsky P, Gelshoj K, Palshof T, Rorth M, Daehnfeldt JL, Rose C.

Eur J Cancer. 1980;Suppl 1:107-10. No abstract available.

PMID:
7032918
192.

Red cell 2.3-diphosphoglycerate in pregnancy.

Bille-Brahe NE, Rørth M.

Acta Obstet Gynecol Scand. 1979;58(1):19-21.

PMID:
419949
193.

Effects of androgens on oxygen affinity in vivo and 2,3-diphosphoglycerate content of red cells in peripheral arterial insufficiency.

Bille-Brahe NE, Kehlet H, Madsbad S, Rörth M.

Scand J Clin Lab Invest. 1976 Dec;36(8):801-4.

PMID:
1031492
194.

The effects of acute bleeding on acid-base balance erythropoietin (Ep) production and in vivo P50 in the rat.

Miller ME, Rörth M, Stohlman F Jr, Valeri CR, Lowrie G, Howard D, McGilvray N.

Br J Haematol. 1976 Jul;33(3):379-85.

PMID:
1276082
195.

The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Parving HH, Noer I, Deckert T, Evrin PE, Nielsen SL, Lyngsoe J, Mogensen CE, Rorth M, Svendsen PA, Trap-Jensen J, Lassen NA.

Diabetologia. 1976 May;12(2):161-6.

PMID:
1269850
196.

Cardiovascular effects of induced hypercarbia during halothane-nitrous oxide anaesthesia.

Bille-Brahe NE, Sorensen MB, Rorth M, Lunding M.

Acta Chir Scand Suppl. 1976;472:127-32.

PMID:
1072549
197.

Physiologic effects of hyperventilation and phlebotomy in baboons: systemic and cerebral oxygen extraction.

Valeri CR, Rorth M, Zaroulis CG, Jakubowski MS, Vescera SV.

Ann Surg. 1975 Jan;181(1):99-105.

199.

Human red cell metabolism and in vivo oxygen affinity of red cells during 24 hours' exposure to simulated high altitude (4500 m).

Rörth M, Nygaard SF, Parving HH, Hansen V, Kalsig T.

Scand J Clin Lab Invest. 1973 Jun;31(4):447-52. No abstract available.

PMID:
4761793
200.

Oxygen affinity of hemoglobin and red cell 2,3-diphosphoglycerate in hepatic cirrhosis.

Astrup J, Rörth M.

Scand J Clin Lab Invest. 1973 May;31(3):311-7. No abstract available.

PMID:
4755036

Supplemental Content

Loading ...
Support Center